A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies

The shady side of dasatinib

(2012) A. Zarbock   BLOOD

An Overview of Current Diagnosis and Treatment in Ovarian Cancer

(2012) Tim Mould   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer

(2011) Muralidharan Anbalagan et al.   BREAST CANCER RESEARCH AND TREATMENT

Src family kinases and paclitaxel sensitivity

(2011) Xiao-Feng Le et al.   CANCER BIOLOGY & THERAPY

Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells

(2011) Lori Rice et al.   CLINICAL & EXPERIMENTAL METASTASIS

Thiazolyl N-benzyl-substituted acetamide derivatives: Synthesis, Src kinase inhibitory and anticancer activities

(2011) Asal Fallah-Tafti et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Current Status of Src Inhibitors in Solid Tumor Malignancies

(2011) L. N. Puls et al.   ONCOLOGIST

Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy

(2010) H. Cai et al.   CANCER RESEARCH

Protein Kinase G Type I  Activity in Human Ovarian Cancer Cells Significantly Contributes to Enhanced Src Activation and DNA Synthesis/Cell Proliferation

(2010) E. L. Leung et al.   MOLECULAR CANCER RESEARCH

Expression of Src and FAK in Hepatocellular Carcinoma and the Effect of Src Inhibitors on Hepatocellular Carcinoma In Vitro

(2008) Grace M. Lau et al.   DIGESTIVE DISEASES AND SCIENCES